Connection

ALEXANDER KAY to Antibiotics, Antitubercular

This is a "connection" page, showing publications ALEXANDER KAY has written about Antibiotics, Antitubercular.
Connection Strength

2.062
  1. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2025 10 23; 10:CD013359.
    View in: PubMed
    Score: 0.911
  2. Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children. Cochrane Database Syst Rev. 2022 09 06; 9:CD013359.
    View in: PubMed
    Score: 0.733
  3. Xpert MTB/RIF Ultra assay for pulmonary tuberculosis and rifampicin resistance in adults and adolescents. Cochrane Database Syst Rev. 2025 07 29; 7:CD009593.
    View in: PubMed
    Score: 0.224
  4. Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children. Cochrane Database Syst Rev. 2020 08 27; 8:CD013359.
    View in: PubMed
    Score: 0.159
  5. Diagnostic and Treatment Monitoring Potential of A Stool-Based Quantitative Polymerase Chain Reaction Assay for Pulmonary Tuberculosis. Am J Trop Med Hyg. 2018 08; 99(2):310-316.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.